Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connie Hess

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peripheral Arterial Disease
39
2023
381
11.480
Why?
Percutaneous Coronary Intervention
22
2021
445
4.740
Why?
Coronary Artery Disease
15
2020
611
4.470
Why?
Myocardial Infarction
18
2023
932
4.180
Why?
Lower Extremity
18
2023
334
4.090
Why?
Platelet Aggregation Inhibitors
24
2023
395
3.550
Why?
Fibrinolytic Agents
9
2022
231
3.060
Why?
Endovascular Procedures
7
2023
267
3.010
Why?
Radial Artery
9
2019
66
2.720
Why?
Purinergic P2Y Receptor Antagonists
8
2018
61
2.470
Why?
Acute Coronary Syndrome
7
2023
254
2.330
Why?
Vascular Surgical Procedures
6
2021
260
2.180
Why?
Aspirin
13
2023
324
2.000
Why?
Rivaroxaban
12
2023
211
1.990
Why?
Ischemia
9
2023
361
1.820
Why?
Stroke
10
2022
1019
1.630
Why?
Femoral Artery
8
2023
165
1.570
Why?
Treatment Outcome
40
2023
9049
1.560
Why?
Anticoagulants
9
2023
547
1.510
Why?
Hemorrhage
15
2023
600
1.480
Why?
Postoperative Complications
6
2021
2122
1.470
Why?
Drug-Eluting Stents
4
2021
62
1.420
Why?
Anticholesteremic Agents
3
2023
129
1.360
Why?
Hypercholesterolemia
2
2022
90
1.310
Why?
Venous Thromboembolism
2
2023
230
1.300
Why?
Atherosclerosis
5
2023
342
1.300
Why?
Patient Readmission
4
2021
607
1.260
Why?
Cardiovascular Diseases
6
2023
1726
1.130
Why?
Atrial Fibrillation
4
2017
325
1.130
Why?
Aged
40
2022
18969
1.090
Why?
Disease Management
4
2021
556
1.060
Why?
Humans
87
2023
114045
1.020
Why?
Ticlopidine
3
2016
54
1.020
Why?
Saphenous Vein
2
2015
31
0.950
Why?
Graft Occlusion, Vascular
2
2015
35
0.950
Why?
Factor Xa Inhibitors
6
2021
138
0.910
Why?
Learning Curve
2
2015
63
0.900
Why?
Female
51
2023
59324
0.900
Why?
Cardiac Catheterization
3
2018
545
0.890
Why?
Coronary Artery Bypass
2
2015
196
0.870
Why?
Thrombosis
3
2022
295
0.870
Why?
Middle Aged
35
2023
26605
0.870
Why?
Pyridones
2
2015
122
0.860
Why?
Male
45
2023
55396
0.860
Why?
Risk Factors
23
2023
8614
0.850
Why?
Warfarin
2
2015
136
0.850
Why?
Sex Characteristics
3
2023
636
0.840
Why?
Fibrin Fibrinogen Degradation Products
1
2023
79
0.830
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2023
373
0.830
Why?
Antifibrinolytic Agents
1
2023
43
0.820
Why?
Postoperative Hemorrhage
2
2013
74
0.810
Why?
Brain Ischemia
2
2022
297
0.790
Why?
Coronary Vessels
3
2023
234
0.760
Why?
Paclitaxel
2
2021
190
0.760
Why?
Blood Coagulation Disorders
1
2023
154
0.750
Why?
Pyrazoles
2
2015
361
0.750
Why?
Diabetes Complications
2
2021
208
0.750
Why?
Heparin
3
2023
225
0.740
Why?
Gout
2
2018
36
0.740
Why?
Hypolipidemic Agents
1
2021
86
0.710
Why?
Angina Pectoris
2
2017
63
0.690
Why?
Dyslipidemias
1
2021
153
0.660
Why?
Leg
1
2021
224
0.660
Why?
Risk Assessment
11
2021
2958
0.630
Why?
Myocardial Revascularization
2
2016
67
0.620
Why?
Reperfusion
1
2018
35
0.610
Why?
Consensus
2
2017
532
0.600
Why?
Drug Therapy, Combination
10
2023
949
0.580
Why?
Upper Extremity
1
2018
83
0.580
Why?
Time Factors
13
2021
6077
0.580
Why?
Databases, Factual
2
2021
1125
0.570
Why?
Coronary Angiography
3
2017
308
0.550
Why?
Registries
10
2019
1764
0.550
Why?
Medicare
4
2021
661
0.510
Why?
Cholesterol, LDL
4
2023
307
0.500
Why?
Acute Disease
4
2021
907
0.490
Why?
Quality Indicators, Health Care
3
2023
285
0.480
Why?
Societies, Medical
2
2023
655
0.480
Why?
Recurrence
5
2020
925
0.460
Why?
Coronary Disease
1
2017
348
0.460
Why?
Follow-Up Studies
6
2021
4392
0.460
Why?
Hospitals
3
2017
581
0.450
Why?
United States
20
2023
12137
0.440
Why?
Office Visits
1
2013
79
0.430
Why?
Sex Factors
7
2022
1706
0.400
Why?
Hematoma
2
2022
50
0.390
Why?
Health Status Disparities
1
2014
200
0.380
Why?
Aftercare
1
2013
186
0.380
Why?
Quality of Life
3
2022
2343
0.380
Why?
Subclavian Vein
1
2011
14
0.370
Why?
Referral and Consultation
1
2016
632
0.370
Why?
Subclavian Artery
1
2011
29
0.360
Why?
Arteriovenous Fistula
1
2011
29
0.360
Why?
Thrombocytopenia
1
2012
177
0.360
Why?
Cardiology
2
2023
260
0.360
Why?
Electric Countershock
1
2011
104
0.350
Why?
Catheterization
1
2011
158
0.350
Why?
Proportional Hazards Models
4
2021
1078
0.330
Why?
Comorbidity
4
2020
1447
0.330
Why?
Adenosine Diphosphate
1
2009
76
0.330
Why?
Cardiovascular Agents
2
2022
125
0.320
Why?
Randomized Controlled Trials as Topic
1
2014
1204
0.320
Why?
Retrospective Studies
8
2022
12521
0.310
Why?
Nitric Oxide Synthase Type III
1
2009
181
0.310
Why?
Healthcare Disparities
1
2014
479
0.310
Why?
AMP-Activated Protein Kinases
1
2009
170
0.300
Why?
Gene Expression Regulation, Enzymologic
1
2009
270
0.300
Why?
Peptides
1
2013
847
0.300
Why?
Prospective Studies
7
2022
6195
0.300
Why?
Defibrillators, Implantable
1
2011
287
0.290
Why?
Cardiomyopathies
1
2011
298
0.290
Why?
Vascular System Injuries
2
2019
66
0.290
Why?
Catheterization, Peripheral
2
2019
100
0.280
Why?
Double-Blind Method
4
2020
1656
0.270
Why?
Cause of Death
3
2018
362
0.270
Why?
Aged, 80 and over
7
2021
6306
0.270
Why?
Neoplasms
2
2017
2086
0.250
Why?
Intermittent Claudication
2
2023
108
0.250
Why?
Ankle Brachial Index
2
2022
31
0.240
Why?
Popliteal Artery
3
2023
57
0.240
Why?
Endothelial Cells
1
2009
677
0.230
Why?
Kaplan-Meier Estimate
3
2021
813
0.230
Why?
Patient Discharge
3
2021
770
0.230
Why?
Age Factors
4
2016
2885
0.230
Why?
Longitudinal Studies
5
2018
2384
0.220
Why?
Arteries
2
2022
246
0.220
Why?
Incidence
5
2021
2314
0.220
Why?
Thromboplastin
1
2023
69
0.210
Why?
Myocardial Ischemia
2
2015
239
0.210
Why?
Numbers Needed To Treat
1
2021
8
0.190
Why?
Walking
2
2022
422
0.190
Why?
Ulcer
1
2021
28
0.190
Why?
Odds Ratio
2
2022
951
0.190
Why?
Lactones
1
2022
54
0.190
Why?
Clinical Trials as Topic
2
2017
926
0.180
Why?
Syndrome
1
2021
330
0.180
Why?
Cholesterol
1
2022
368
0.180
Why?
Angioplasty, Balloon
1
2021
89
0.180
Why?
Limb Salvage
1
2020
51
0.180
Why?
Antineoplastic Agents, Phytogenic
1
2021
181
0.170
Why?
Hospitalization
2
2019
1762
0.170
Why?
Hypertension
2
2022
1052
0.170
Why?
United Kingdom
1
2020
226
0.170
Why?
Pharmaceutical Preparations
1
2021
164
0.160
Why?
Secondary Prevention
1
2020
221
0.160
Why?
Extremities
1
2020
111
0.160
Why?
Aorta
1
2021
388
0.160
Why?
Receptors, Purinergic P2Y12
1
2018
5
0.160
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2018
22
0.160
Why?
Cohort Studies
2
2022
4883
0.160
Why?
Pyridines
1
2022
419
0.150
Why?
Exercise Therapy
1
2022
351
0.150
Why?
Antithrombins
1
2018
49
0.150
Why?
Stents
3
2020
466
0.150
Why?
Practice Guidelines as Topic
2
2017
1381
0.150
Why?
Non-ST Elevated Myocardial Infarction
1
2017
16
0.150
Why?
American Heart Association
3
2023
264
0.140
Why?
Plaque, Atherosclerotic
1
2017
46
0.140
Why?
ST Elevation Myocardial Infarction
1
2017
50
0.140
Why?
Mortality
1
2018
283
0.130
Why?
Intraoperative Complications
1
2017
120
0.130
Why?
Uric Acid
1
2017
148
0.130
Why?
Antibodies, Monoclonal
2
2023
1257
0.130
Why?
Blood Platelets
1
2018
326
0.130
Why?
North Carolina
1
2015
83
0.120
Why?
Hospital Bed Capacity
1
2014
22
0.120
Why?
Smoking
1
2022
1382
0.120
Why?
Hospitals, Low-Volume
1
2014
22
0.120
Why?
Hospitals, High-Volume
1
2014
38
0.120
Why?
Clinical Trials Data Monitoring Committees
1
2014
5
0.120
Why?
Vascular Patency
1
2014
97
0.120
Why?
Prosthesis Design
2
2017
283
0.110
Why?
Diabetes Mellitus
1
2022
898
0.110
Why?
Diagnosis-Related Groups
1
2013
26
0.110
Why?
Survivors
1
2017
412
0.110
Why?
Professional Competence
1
2014
81
0.110
Why?
Logistic Models
1
2018
1829
0.110
Why?
Guideline Adherence
1
2017
489
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2017
660
0.110
Why?
Practice Patterns, Physicians'
2
2018
1175
0.110
Why?
Fee-for-Service Plans
1
2013
83
0.110
Why?
Inflammation
1
2023
2464
0.100
Why?
Platelet Factor 4
1
2012
21
0.100
Why?
Infusions, Intravenous
1
2013
370
0.100
Why?
Heart Failure
2
2016
1958
0.100
Why?
Prognosis
2
2021
3315
0.090
Why?
Radiography, Interventional
1
2011
105
0.090
Why?
Hospital Mortality
1
2014
773
0.080
Why?
Naphthalimides
1
2009
2
0.080
Why?
Calcium-Calmodulin-Dependent Protein Kinase Kinase
1
2009
3
0.080
Why?
Heart Diseases
1
2013
329
0.080
Why?
Predictive Value of Tests
1
2014
1791
0.080
Why?
Sensitivity and Specificity
1
2013
1690
0.080
Why?
Communication
1
2014
734
0.080
Why?
Benzimidazoles
1
2009
137
0.080
Why?
Protein Isoforms
1
2009
337
0.080
Why?
Case-Control Studies
1
2015
3003
0.080
Why?
Combined Modality Therapy
2
2021
1117
0.070
Why?
Enzyme Activation
1
2009
771
0.070
Why?
Phosphatidylinositol 3-Kinases
1
2009
328
0.070
Why?
Clinical Competence
1
2014
882
0.070
Why?
Quality Improvement
1
2014
944
0.070
Why?
Cattle
1
2009
918
0.070
Why?
Young Adult
1
2021
10444
0.070
Why?
Cell Movement
1
2009
863
0.060
Why?
Phosphorylation
1
2009
1558
0.060
Why?
Autoantibodies
1
2012
1347
0.060
Why?
Prevalence
2
2021
2247
0.050
Why?
Subtilisin
1
2023
3
0.050
Why?
Proprotein Convertases
1
2023
14
0.050
Why?
Lipoprotein(a)
1
2023
51
0.050
Why?
Adolescent
1
2021
17800
0.050
Why?
Proprotein Convertase 9
1
2023
61
0.050
Why?
Diabetes Mellitus, Type 2
1
2016
2087
0.050
Why?
Mobility Limitation
1
2022
60
0.050
Why?
Public Health Surveillance
1
2021
61
0.050
Why?
Coated Materials, Biocompatible
1
2021
54
0.050
Why?
Diagnostic Tests, Routine
1
2021
87
0.040
Why?
Adult
1
2021
30375
0.040
Why?
Internationality
1
2020
143
0.040
Why?
Advisory Committees
1
2021
207
0.040
Why?
Disease Susceptibility
1
2021
316
0.040
Why?
Punctures
1
2019
36
0.040
Why?
Global Health
1
2021
284
0.040
Why?
Reoperation
1
2021
513
0.040
Why?
Drug Utilization Review
1
2017
56
0.040
Why?
Health Care Costs
1
2021
381
0.040
Why?
Socioeconomic Factors
1
2021
1080
0.040
Why?
Dose-Response Relationship, Drug
1
2021
1836
0.030
Why?
Surgery, Computer-Assisted
1
2017
61
0.030
Why?
Signal Transduction
1
2009
4501
0.030
Why?
Comparative Effectiveness Research
1
2017
131
0.030
Why?
Chi-Square Distribution
1
2017
492
0.030
Why?
Drug Prescriptions
1
2017
237
0.030
Why?
Patient Selection
1
2019
629
0.030
Why?
Platelet Function Tests
1
2015
21
0.030
Why?
Administration, Oral
1
2017
725
0.030
Why?
Mass Screening
1
2021
979
0.030
Why?
Early Termination of Clinical Trials
1
2014
14
0.030
Why?
Multivariate Analysis
1
2017
1422
0.030
Why?
Retreatment
1
2013
67
0.030
Why?
Canada
1
2014
320
0.030
Why?
Patient Preference
1
2014
164
0.030
Why?
Linear Models
1
2014
768
0.020
Why?
Pregnancy
1
2023
5499
0.020
Why?
Animals
1
2009
31565
0.020
Why?
Hess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)